| scholarly article | Q13442814 |
| P50 | author | Xiang-Ming Lao | Q46110276 |
| P2093 | author name string | Jun-Cheng Wang | |
| Zhen-Xin Chen | |||
| Jing-Yuan Peng | |||
| Xi-Wen Wu | |||
| Zhi-Wei Jian | |||
| P2860 | cites work | Percutaneous ethanol injection for hepatocellular carcinoma: 20-year outcome and prognostic factors | Q24630594 |
| Global cancer statistics, 2012 | Q27860501 | ||
| EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma | Q27860783 | ||
| Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival | Q29616865 | ||
| Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial | Q29617955 | ||
| Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma | Q29617957 | ||
| Unresectable Hepatocellular Carcinoma: Radioembolization Versus Chemoembolization: A Systematic Review and Meta-analysis. | Q30248206 | ||
| Transarterial chemoembolization as initial treatment for unresectable hepatocellular carcinoma in southern China | Q33590853 | ||
| Categorizing a prognostic variable: review of methods, code for easy implementation and applications to decision-making about cancer treatments | Q33810098 | ||
| Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level | Q34481474 | ||
| Novel advancements in the management of hepatocellular carcinoma in 2008. | Q34588842 | ||
| Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design. | Q34635723 | ||
| Clinical characteristics, treatment, and prognosis of non-B, non-C hepatocellular carcinoma: a large retrospective multicenter cohort study. | Q35156568 | ||
| Obesity Does Not Influence Outcomes in Hepatocellular Carcinoma Patients following Curative Hepatectomy | Q35597611 | ||
| Impact of oral anti-hepatitis B therapy on the survival of patients with hepatocellular carcinoma initially treated with chemoembolization | Q36121202 | ||
| Comparison between chemoembolization combined with radiotherapy and chemoembolization alone for large hepatocellular carcinoma | Q36178891 | ||
| Efficacy and safety of transarterial radioembolization versus chemoembolization in patients with hepatocellular carcinoma. | Q36673829 | ||
| The Relation between Obesity and Survival after Surgical Resection of Hepatitis C Virus-Related Hepatocellular Carcinoma | Q36848551 | ||
| Prognostic analysis of pulmonary metastases from hepatocellular carcinoma | Q37278121 | ||
| EASL Clinical Practice Guidelines: management of chronic hepatitis B. | Q37340737 | ||
| The impact of body mass index on complication and survival in resected oesophageal cancer: a clinical-based cohort and meta-analysis | Q37352604 | ||
| Transarterial chemoembolization for hepatitis B virus-associated hepatocellular carcinoma: improved survival after concomitant treatment with nucleoside analogues | Q37977666 | ||
| Transarterial chemoembolization combined with percutaneous radiofrequency ablation versus TACE and PRFA monotherapy in the treatment for hepatocellular carcinoma: a meta-analysis | Q38071906 | ||
| Clinical management of obese patients with cancer | Q38121736 | ||
| Transarterial chemoembolization: modalities, indication, and patient selection | Q38355409 | ||
| Epidemiology of hepatocellular carcinoma: target population for surveillance and diagnosis | Q38667063 | ||
| EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection | Q38692559 | ||
| PD-1hi Identifies a Novel Regulatory B-cell Population in Human Hepatoma That Promotes Disease Progression. | Q38790070 | ||
| In intermediate stage hepatocellular carcinoma: radioembolization with yttrium 90 or chemoembolization? | Q38984450 | ||
| Actual 10-Year Survivors After Resection of Hepatocellular Carcinoma | Q40439753 | ||
| Transcatheter arterial chemoembolization as primary treatment for hepatocellular carcinoma | Q40637515 | ||
| Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update | Q41962614 | ||
| Preoperative hepatitis B virus DNA level is a risk factor for postoperative liver failure in patients who underwent partial hepatectomy for hepatitis B-related hepatocellular carcinoma | Q42227308 | ||
| Effect of antiviral treatment with nucleotide/nucleoside analogs on postoperative prognosis of hepatitis B virus-related hepatocellular carcinoma: a two-stage longitudinal clinical study | Q42272323 | ||
| Hepatitis B virus-DNA level and basal core promoter A1762T/G1764A mutation in liver tissue independently predict postoperative survival in hepatocellular carcinoma | Q42476586 | ||
| The impact of obesity and diabetes mellitus on the risk of hepatocellular carcinoma. | Q42981023 | ||
| Effect of body mass index on survival after curative therapy for non-B non-C hepatocellular carcinoma | Q43565161 | ||
| Longterm prognosis after hepatic resection for small hepatocellular carcinoma | Q44816087 | ||
| A comparison of chemoembolization combination with and without radiotherapy for unresectable hepatocellular carcinoma. | Q45141892 | ||
| Association between nucleoside analogues and risk of hepatitis B virus–related hepatocellular carcinoma recurrence following liver resection | Q45353860 | ||
| High viral load is associated with poor overall and recurrence-free survival of hepatitis B virus-related hepatocellular carcinoma after curative resection: a prospective cohort study | Q45357441 | ||
| Impact of antiviral therapy on the survival of patients after major hepatectomy for hepatitis B virus-related hepatocellular carcinoma | Q45365588 | ||
| Changes in hepatitis B virus DNA levels and liver function after transcatheter arterial chemoembolization of hepatocellular carcinoma. | Q45366225 | ||
| Combination transarterial chemoembolization and microwave ablation improves local tumor control for 3- to 5-cm hepatocellular carcinoma when compared with transarterial chemoembolization alone. | Q49950346 | ||
| Superselective transarterial chemoembolization for hepatocellular carcinoma. Validation of treatment algorithm proposed by Japanese guidelines. | Q51472261 | ||
| Clinicopathologic features of hepatocellular carcinoma patients with compensated cirrhosis surviving more than 10 years after curative hepatectomy. | Q51770636 | ||
| Epidemiology of Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Related Hepatocellular Carcinoma. | Q52355121 | ||
| Hepatic Resection after Initial Transarterial Chemoembolization Versus Transarterial Chemoembolization Alone for the Treatment of Hepatocellular Carcinoma: A Meta-analysis of Observational Studies. | Q53257063 | ||
| Skeletal muscle fat deposition is associated with hepatocellular carcinoma development in patients with chronic liver disease. | Q54213840 | ||
| Comparison of the Efficacy and Prognostic Factors of Transarterial Chemoembolization Plus Microwave Ablation versus Transarterial Chemoembolization Alone in Patients with a Large Solitary or Multinodular Hepatocellular Carcinomas. | Q55003707 | ||
| Hepatocellular carcinoma | Q58020832 | ||
| Impact of myosteatosis on skeletal muscle volume loss in patients with chronic liver disease | Q58378572 | ||
| Long-term prognosis of patients undergoing transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: comparison of cisplatin lipiodol suspension and doxorubicin hydrochloride emulsion | Q74130294 | ||
| Ten-year survival of patients with hepatocellular carcinoma after hepatectomy | Q80122746 | ||
| Meta-analysis: the efficacy of anti-viral therapy in prevention of recurrence after curative treatment of chronic hepatitis B-related hepatocellular carcinoma | Q83849435 | ||
| The effect of overweight status on the short-term and 20-y outcomes after hepatic resection in patients with hepatocellular carcinoma | Q84472840 | ||
| Impact of severe malnutrition on short-term mortality and overall survival in head and neck cancer | Q84623052 | ||
| Central obesity early in adulthood may affect outcomes of hepatocellular carcinoma | Q86367025 | ||
| Effect of Nucleos(t)ide Analogs on Patients with Intermediate and Advanced Hepatitis B Virus-Related Hepatocellular Carcinoma | Q91993705 | ||
| P433 | issue | 11 | |
| P921 | main subject | hepatocellular carcinoma | Q1148337 |
| P304 | page(s) | 5097-5107 | |
| P577 | publication date | 2019-07-17 | |
| P1433 | published in | Cancer Medicine | Q27724564 |
| P1476 | title | Clinical conditions and treatment requirements for long-term survival among hepatitis B-related hepatocellular carcinoma initially treated with chemoembolization | |
| P478 | volume | 8 |
Search more.